Better management of diabetes leads to fewer re-admissions, study says
By HME News Staff
Updated Tue November 15, 2016
WALTHAM, Mass. - Two new studies validate the ability of Glytec's eGlycemic Management System to reduce readmissions for patient populations at the center of new at-risk and value-based reimbursement models, the company says. Both studies, presented earlier this month at the Diabetes Technology Meeting, compare outcomes of cardiovascular patients receiving care with eGMS to outcomes of those receiving standard care. The data shows cardiovascular patients receiving care with eGMS return to the hospital far less frequently, with reductions in risk-adjusted 30-day readmissions as high as 68%. The basis for the studies was a system-wide glycemic initiative launched by Mountain States Health Alliance, which operates 13 hospitals. Like most health systems, the alliance has been challenged to initiate timely therapy for patients with undocumented, undiagnosed or stress-induced diabetes. One of the key benefits of eGMS is a GlucoSurveillance module that alerts care teams to patients with blood glucose outside a designated range. Glytec specializes in integrated inpatient and outpatient technologies for diabetes care.
Comments